Repurposing the Bis-Biguanide Alexidine in Combination with Tyrosine Kinase Inhibitors to Eliminate Leukemic Stem/Progenitor Cells in Chronic Myeloid Leukemia

por Muselli, Fabien, Mourgues, Lucas, Rochet, Nathalie, Nebout, Marielle, Guerci, Agnès, Verhoeyen, Els, Krug, Adrien, Legros, Laurence, Peyron, Jean-François, Mary, Didier
Publicado 2023

Progressive erythrocytosis under lenvatinib treatment in patients with advanced hepatocellular carcinoma

por Legros, Laurence, Pascale, Alina, Guettier, Catherine, Eftekhari, Pirayeh, Merabet, Yasmina Ben, Stang, Maryse, Bossevot, Rachel, Goldschmidt, Emma, Ulusakarya, Ayhan, Morisset, Stephane, Lewin, Maïté, Samuel, Didier, Rosmorduc, Olivier
Publicado 2023

All tyrosine kinase inhibitor-resistant chronic myelogenous cells are highly sensitive to Ponatinib

por Cassuto, Ophélie, Dufies, Maeva, Jacquel, Arnaud, Robert, Guillaume, Ginet, Clémence, Dubois, Alix, Hamouda, Amine, Puissant, Alexandre, Luciano, Fredéric, Karsenti, Jean-Michel, Legros, Laurence, Cassuto, Jill Patrice, Lenain, Pascal, Auberger, Patrick
Publicado 2012

Combination of PKCδ Inhibition with Conventional TKI Treatment to Target CML Models

por Muselli, Fabien, Mourgues, Lucas, Morcos, Rita, Rochet, Nathalie, Nebout, Marielle, Guerci-Bresler, Agnès, Faller, Douglas V, William, Robert M, Mhaidly, Rana, Verhoeyen, Els, Legros, Laurence, Peyron, Jean-François, Mary, Didier
Publicado 2021

Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuation

por Chomel, Jean Claude, Bonnet, Marie Laure, Sorel, Nathalie, Sloma, Ivan, Bennaceur-Griscelli, Annelise, Rea, Delphine, Legros, Laurence, Marfaing-Koka, Anne, Bourhis, Jean-Henri, Ame, Shanti, Guerci-Bresler, Agnès, Rousselot, Philippe, Turhan, Ali G.
Publicado 2016

Clinical Added Value of SARS-CoV-2 Antigen Detection in Blood Samples

por Oueslati, Saoussen, Manai Bouokazi, Melek, Ramdhani, Ikrame, Escaut, Lélia, Pham, Tài, Ouzani, Souad, Anguel, Nadia, Bulifon, Sophie, Vauloup-Fellous, Christelle, Coilly, Audrey, Legros, Laurence, Guichardon, Magali, Fortineau, Nicolas, Dortet, Laurent, Roque-Afonso, Anne-Marie, Naas, Thierry
Publicado 2022

Onset of blast crisis in chronic myeloid leukemia patients in treatment-free remission

por Dulucq, Stephanie, Hayette, Sandrine, Cayuela, Jean-Michel, Bauduer, Frédéric, Chabane, Kaddour, Chevallier, Patrice, Cony-Makhoul, Pascale, Flandrin-Gresta, Pascale, Le Jeune, Caroline, Le Bris, Yannick, Legros, Laurence, Maisonneuve, Hervé, Roy, Lydia, Mahon, Francois-Xavier, Sloma, Ivan, Rea, Delphine, Nicolini, Franck Emmanuel
Publicado 2022

Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study

por Rousselot, Philippe, Prost, Stéphane, Guilhot, Joelle, Roy, Lydia, Etienne, Gabriel, Legros, Laurence, Charbonnier, Aude, Coiteux, Valérie, Cony‐Makhoul, Pascale, Huguet, Francoise, Cayssials, Emilie, Cayuela, Jean‐Michel, Relouzat, Francis, Delord, Marc, Bruzzoni‐Giovanelli, Heriberto, Morisset, Laure, Mahon, François‐Xavier, Guilhot, François, Leboulch, Philippe
Publicado 2016

Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study

por Rea, Delphine, Henry, Guylaine, Khaznadar, Zena, Etienne, Gabriel, Guilhot, François, Nicolini, Franck, Guilhot, Joelle, Rousselot, Philippe, Huguet, Françoise, Legros, Laurence, Gardembas, Martine, Dubruille, Viviane, Guerci-Bresler, Agnès, Charbonnier, Aude, Maloisel, Frédéric, Ianotto, Jean-Christophe, Villemagne, Bruno, Mahon, François-Xavier, Moins-Teisserenc, Hélène, Dulphy, Nicolas, Toubert, Antoine
Publicado 2017

Benefits and pitfalls of pegylated interferon-α2a therapy in patients with myeloproliferative neoplasm-associated myelofibrosis: a French Intergroup of Myeloproliferative neoplasms...

por Ianotto, Jean-Christophe, Chauveau, Aurélie, Boyer-Perrard, Françoise, Gyan, Emmanuel, Laribi, Kamel, Cony-Makhoul, Pascale, Demory, Jean-Loup, de Renzis, Benoit, Dosquet, Christine, Rey, Jerome, Roy, Lydia, Dupriez, Brigitte, Knoops, Laurent, Legros, Laurence, Malou, Mohamed, Hutin, Pascal, Ranta, Dana, Benbrahim, Omar, Ugo, Valérie, Lippert, Eric, Kiladjian, Jean-Jacques
Publicado 2018

A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure

por Sébert, Marie, Renneville, Aline, Bally, Cécile, Peterlin, Pierre, Beyne-Rauzy, Odile, Legros, Laurence, Gourin, Marie-Pierre, Sanhes, Laurence, Wattel, Eric, Gyan, Emmanuel, Park, Sophie, Stamatoullas, Aspasia, Banos, Anne, Laribi, Kamel, Jueliger, Simone, Bevan, Luke, Chermat, Fatiha, Sapena, Rosa, Nibourel, Olivier, Chaffaut, Cendrine, Chevret, Sylvie, Preudhomme, Claude, Adès, Lionel, Fenaux, Pierre
Publicado 2019

Imatinib Optimized Therapy Improves Major Molecular Response Rates in Patients with Chronic Myeloid Leukemia

por Johnson-Ansah, Hyacinthe, Maneglier, Benjamin, Huguet, Françoise, Legros, Laurence, Escoffre-Barbe, Martine, Gardembas, Martine, Cony-Makhoul, Pascale, Coiteux, Valérie, Sutton, Laurent, Abarah, Wajed, Pouaty, Camille, Pignon, Jean-Michel, Choufi, Bachra, Visanica, Sorin, Deau, Bénédicte, Morisset, Laure, Cayssials, Emilie, Molimard, Mathieu, Bouchet, Stéphane, Mahon, François-Xavier, Nicolini, Franck, Aegerter, Philippe, Cayuela, Jean-Michel, Delord, Marc, Bruzzoni-Giovanelli, Heriberto, Rousselot, Philippe
Publicado 2022

Impact of the COVID-19 Epidemic on Patients with Myeloproliferative Neoplasia: The French Prospective Observational Study Covim

por Legros, Laurence, Boyer perrard, Françoise, Ranta, Dana, Roy, Lydia, Ojeda-Uribe, Mario, Giraudier, Stephane, Parquet, Nathalie, Ianotto, Jean Christophe, Wemeau, Mathieu, Plantier, Isabelle, Nicolini, Franck E., Lippert, Eric, Cony-Makhoul, Pascale, Barraco, Fiorenza, Stalnikiewicz, Laure, Garban, Frederic, Dupriez, Brigitte, Girodon, Francois, Brignier, Anne, Arkam, Yazid, Meunier, Mathieu, James, Chloe, Rolland-Neyret, Valérie, Ugo, Valerie, Morel, Pierre, Bene, Marie C, Kiladjian, Jean-Jacques
Publicado 2022

Kinetics of early and late molecular recurrences after first-line imatinib cessation in chronic myeloid leukemia: updated results from the STIM2 trial

por Dulucq, Stéphanie, Nicolini, Franck E., Rea, Delphine, Cony-Makhoul, Pascale, Charbonnier, Aude, Escoffre-Barbe, Martine, Coiteux, Valérie, Lenain, Pascal, Rigal-Huguet, Françoise, Liu, Jixing, Guerci-Bresler, Agnès, Legros, Laurence, Ianotto, Jean-Christophe, Gardembas, Martine, Turlure, Pascal, Dubruille, Viviane, Rousselot, Philippe, Martiniuc, Juliana, Jardel, Henry, Johnson-Ansah, Hyacinthe, Joly, Bertrand, Henni, Tawfiq, Cayssials, Emilie, Zunic, Patricia, Berger, Marc G., Villemagne, Bruno, Robbesyn, Fanny, Morisset, Stephane, Mahon, François-Xavier, Etienne, Gabriel
Publicado 2022

Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs

por Sobas, Marta, Kiladjian, Jean-Jacques, Beauverd, Yan, Curto-Garcia, Natalia, Sadjadian, Parvis, Shih, Lee Yung, Devos, Timothy, Krochmalczyk, Dorota, Galli, Serena, Bieniaszewska, Maria, Seferynska, Ilona, McMullin, Mary Frances, Armatys, Anna, Spalek, Adrianna, Waclaw, Joanna, Zdrenghea, Mihnea, Legros, Laurence, Girodon, François, Lewandowski, Krzysztof, Angona Figueras, Anna, Samuelsson, Jan, Abuin Blanco, Aitor, Cony-Makhoul, Pascale, Collins, Angela, James, Chloé, Kusec, Rajko, Lauermannova, Marie, Noya, Maria Sol, Skowronek, Malgorzata, Szukalski, Lukasz, Szmigielska-Kaplon, Anna, Wondergem, Marielle, Dudchenko, Iryna, Gora Tybor, Joanna, Laribi, Kamel, Kulikowska de Nalecz, Anna, Demory, Jean-Loup, Le Du, Katell, Zweegman, Sonja, Besses Raebel, Carlos, Skoda, Radek, Giraudier, Stéphane, Griesshammer, Martin, Harrison, Claire N., Ianotto, Jean-Christophe
Publicado 2022